Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Royalty Management expands investment in Ferrox Holdings to over 10% equity ownership and ZyVersa Therapeutics adds two leading nephrologists to its Renal Scientific Advisory Board
American Acquisition Opportunity’s Target, Royalty Management, Expands Investment in Ferrox Holdings to Over 10% Equity Ownership
American Acquisition Opportunity Inc.’s (NASDAQ:AMAO) merger target company, Royalty Management Corporation (RMC), a sustainably driven, cash flow-oriented, royalty investment and development company, announced today that it has expanded its stake in one of its portfolio holdings, Ferrox Holdings Ltd. (“Ferrox”) through a common stock issuance; issuing stock in Royalty Management Corporation for approximately 10% of Ferrox. The common stock issued by Royalty Management Corporation for its investment in Ferrox is valued at $10.00 per share equivalent of American Acquisition Opportunity’s stock post the pending merger.
READZyVersa Therapeutics Adds Two Esteemed Leaders in Nephrology to Its Renal Scientific Advisory Board to Support Clinical Advancement of Lead Renal Drug Candidate, VAR 200
ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases, announces that two leading nephrologists, Daniel Cattran and Fernando Fervenza, have joined ZyVersa’s Renal Scientific Advisory Board.
READ
An In-Depth Look at SPAC Activity Throughout the Third Quarter of 2023 Below is a summary of the year-to-date SPAC performance. We’re now three-quarters of the way through 2023 and while activity remains muted, there is a sense that SPACs have run the most difficult part of the “correction” gauntlet and have reached a better...
Terms Tracker for the Week Ending September 29, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As September comes to a close, SPACs did not price any IPOs during the month with the most recent IPO (99 Acquisition Group) having priced...
Athena Consumer Acquisition Corp. (NYSE:ACAQ) announced this afternoon that its stockholders approved its combination with German EV-maker e.GO at a special meeting held earlier today. Additionally, Athena Consumer’s warrant proposal to convert all outstanding warrants to 0.175 shares in the combined company was also approved. A total of 884,880 shares of Athena Class A Common...
October is set to be a quiet month for lock-up expirations with only four de-SPACs and four sponsors now open to trade their shares for the first time. The first customer is Bitdeer Technologies. Its shareholders and the Blue Safari sponsor both stand to gain the most out of this group from moving some of...
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that its shareholders approved its combination with NKGen Biotech at a special meeting September 25. A total of 3,386,528 shares were redeemed in connection with the vote, leaving Graf IV with about $27.6 million in the tank and a final redemption rate of 84.3%....